Indication
In adults for the thrombolytic treatment of acute ischaemic stroke (AIS) within 4.5 hours from last known well and after exclusion of intracranial haemorrhage.
Medicine details
- Medicine name:
- teneteplase (Metalyse)
- SMC ID:
- SMC2697
- Pharmaceutical company
- Boehringer Ingelheim Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Abbreviated
- Publication due date:
- 11 November 2024